GEN:NASDAQGen Digital Inc. Analysis
Data as of 2026-03-13 - not real-time
$20.68
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Gen Digital is trading at $20.68, essentially hugging its 30‑day support of $20.61, while the 20‑day SMA (22.26) sits below the 50‑day SMA (24.01), signaling a short‑term downtrend. Technical indicators are mixed: the RSI of 29 points to oversold conditions, yet the MACD histogram remains negative and the overall trend is bearish, with volume trending downward. Volatility is elevated at 42% over the past month, and the stock has endured a max drawdown of about 35%, underscoring heightened price swings. On the fundamental side, the company posted a 26% YoY revenue surge to $1.24 B in Q3 FY2026, beating consensus, and bookings rose 27% driven by AI‑enabled safety solutions. Operating margin stands at 36%, gross margin at 79%, and free cash flow exceeds $1.3 B, supporting a dividend yield of 2.38% with a payout ratio just above 50%. However, the balance sheet is leveraged, reflected by a debt‑to‑equity ratio of 363% and total debt of $8.47 B. The DCF‑derived fair value of $66.84 suggests roughly a 50% upside potential, while the forward PE of 7.2 indicates cheap valuation relative to earnings growth. Analyst consensus remains positive (Buy) with a median target near $32, implying a further upside of about 55% from current levels.
In summary, Gen Digital combines strong top‑line momentum and attractive valuation metrics, but it faces near‑term technical weakness and a high‑debt profile that could limit upside if market sentiment remains bearish. The recent earnings beat and AI‑driven product rollout provide a catalyst for medium‑term recovery, while the dividend and cash generation lend some defensive qualities. Investors should weigh the upside from undervaluation against the risks of volatility, leverage, and a still‑bearish price action pattern.
In summary, Gen Digital combines strong top‑line momentum and attractive valuation metrics, but it faces near‑term technical weakness and a high‑debt profile that could limit upside if market sentiment remains bearish. The recent earnings beat and AI‑driven product rollout provide a catalyst for medium‑term recovery, while the dividend and cash generation lend some defensive qualities. Investors should weigh the upside from undervaluation against the risks of volatility, leverage, and a still‑bearish price action pattern.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near strong support and oversold RSI
- Bearish MACD and decreasing volume
- Recent earnings beat but technical momentum remains weak
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust 26% revenue growth and 27% bookings increase
- Forward PE of 7.2 indicating cheap earnings valuation
- AI‑driven product pipeline expanding paid customer base
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value implying ~50% upside
- Strong cash flow generation supporting dividend sustainability
- High leverage requiring monitoring but offset by operating profitability
Key Metrics & Analysis
Financial Health
Revenue Growth25.80%
Profit Margin12.76%
P/E Ratio21.3
ROE26.90%
ROA7.17%
Debt/Equity363.38
P/B Ratio5.4
Op. Cash Flow$1.5B
Free Cash Flow$1.3B
Industry P/E33.7
Technical Analysis
TrendBearish
RSI29.3
Support$20.61
Resistance$23.97
MA 20$22.26
MA 50$24.01
MA 200$27.40
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value$66.84
Target Price$31.19
Upside/Downside50.81%
GradeUndervalued
TypeBlend
Dividend Yield2.38%
Risk Assessment
Beta0.97
Volatility42.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.